‘Lot of scope and infrastructure for manufacture of vaccine in India’ Government officials who are sitting on the “untapped potential” of India to manufacture COVID-19 vaccine should be charged with “manslaughter”, the Delhi High Court warned on Wednesday. “There is a lot of scope and infrastructure for manufacture of vaccine in India. And this matter, you (Centre) must really consider. This untapped potential has to be utilised. Your officers are not realising this,” a Bench of Justice Manmohan and Justice Najmi Waziri said. The court’s observation came while hearing a plea of Delhi-based Panacea Biotec, which has sought the release of an arbitral award passed in its favour and against the Centre, saying it needs funds at the earliest in the larger interest of humanity as it has already manufactured trial batches of Sputnik V vaccine in collaboration with Russian Direct Investment Fund and wants to scale it up.